Form 4: Codexis CFO Sells Shares for Tax Obligations

Codexis' Chief Financial Officer, Georgia Erbez, sold 3,826 shares of common stock to cover tax withholding obligations related to RSU vesting.

Summary

• Georgia Erbez, Chief Financial Officer and Chief Business Officer of Codexis, Inc. (CDXS), reported a transaction on February 6, 2026.
• Erbez disposed of 3,826 shares of Codexis Common Stock at a price of $1.3071 per share.
• The sale was executed solely to satisfy tax or other government withholding obligations associated with the vesting of Restricted Stock Units (RSUs).
• Following this transaction, Georgia Erbez beneficially owns 66,810 shares of Common Stock, which includes 24,374 restricted stock units.
• The transaction was made pursuant to a Rule 10b5-1(c) pre-planned contract, instruction, or written plan.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event. The sale is a non-discretionary transaction for tax purposes, which is a common occurrence for executives receiving equity compensation and does not reflect a change in sentiment towards the company.

Positives

• The transaction was conducted under a Rule 10b5-1(c) plan, indicating a pre-planned, non-discretionary sale, which can reduce concerns about insider trading.
• The sale was explicitly for tax withholding obligations related to RSU vesting, a common and routine event for executives receiving equity compensation.

Negatives

• No specific negative aspects are identified from this routine, non-discretionary transaction for tax purposes.

Future Outlook

This filing does not contain any forward-looking statements or guidance regarding the company's future outlook.

Industry Context

StockSavvy.ai notes that sales of shares by executives to cover tax obligations upon the vesting of restricted stock units are a standard practice across all industries. This type of transaction is generally not indicative of a change in management's outlook on the company's prospects, but rather a necessary step in managing equity compensation.

Comparison to Industry Standards

• This transaction aligns with common industry practices for executive compensation and tax management. Many public company executives, including those at biotech firms like Amgen or Gilead Sciences, routinely sell a portion of their vested equity awards to cover statutory tax withholdings.

Stakeholder Impact

• Shareholders: This routine transaction is unlikely to have a significant direct impact on shareholders, as it's a standard part of executive compensation management and not a discretionary sale based on company performance or outlook.

Key Dates

Recommendation

This Form 4 filing details a routine, non-discretionary sale of shares by an executive to cover tax obligations related to RSU vesting. Such transactions are common and do not typically signal a change in the company's fundamentals or management's confidence. Therefore, this filing alone does not provide sufficient information to alter an existing investment thesis, warranting a 'hold' recommendation based solely on this specific disclosure.

Keywords

Codexis, CDXS, Insider Trading, Form 4, Stock Sale, Tax Withholding, Restricted Stock Units, RSU Vesting, Executive Compensation, Georgia Erbez, CFO